The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
[22-hydroxycholesterol co-treated with Alitretinoin] results in increased expression of ABCA1 mRNA; [22-hydroxycholesterol co-treated with Alitretinoin] results in increased expression of ABCA1 protein [22-hydroxycholesterol co-treated with Alitretinoin] results in increased expression of ABCA1 protein; [Alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of ABCA1 mRNA; [Alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of ABCA1 protein; Arsenic Trioxide inhibits the reaction [[Alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of ABCA1 mRNA]; Arsenic Trioxide inhibits the reaction [[Alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of ABCA1 protein] 22-hydroxycholesterol results in increased expression of ABCA1 mRNA
22-hydroxycholesterol results in increased expression of ALDH1A2 mRNA 22-hydroxycholesterol promotes the reaction [SREBF1 protein binds to ALDH1A2 promoter]
22-hydroxycholesterol results in increased expression of CCL2 mRNA [22-hydroxycholesterol co-treated with Alitretinoin] inhibits the reaction [IFNG promotes the reaction [STAT1 protein binds to CCL2 promoter]]
22-hydroxycholesterol binds to and results in decreased activity of ESR1 protein; 22-hydroxycholesterol inhibits the reaction [Estradiol results in increased activity of ESR1 protein]
22-hydroxycholesterol binds to and results in decreased activity of ESR2 protein; 22-hydroxycholesterol inhibits the reaction [Estradiol results in increased activity of ESR2 protein]
22-hydroxycholesterol results in increased expression of ICAM1 mRNA 22-hydroxycholesterol promotes the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA]; 22-hydroxycholesterol promotes the reaction [TNF protein results in increased expression of ICAM1 mRNA]
22-hydroxycholesterol inhibits the reaction [IFNG results in increased expression of NR1H3 mRNA]; 22-hydroxycholesterol inhibits the reaction [IFNG results in increased phosphorylation of and results in increased localization of STAT1 protein]; [22-hydroxycholesterol co-treated with Alitretinoin] inhibits the reaction [IFNG promotes the reaction [STAT1 protein binds to CCL2 promoter]]; [22-hydroxycholesterol co-treated with Alitretinoin] inhibits the reaction [IFNG results in increased expression of STAT1 mRNA]
[Alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of LPL mRNA 22-hydroxycholesterol results in increased expression of LPL mRNA
22-hydroxycholesterol binds to and results in increased activity of NR1H3 protein; 22-hydroxycholesterol inhibits the reaction [IFNG results in increased expression of NR1H3 mRNA]; 22-hydroxycholesterol promotes the reaction [Pioglitazone results in increased expression of NR1H3 mRNA]; 22-hydroxycholesterol promotes the reaction [Rosiglitazone results in increased expression of NR1H3 mRNA]; [Alitretinoin co-treated with 22-hydroxycholesterol] affects the localization of NR1H3 protein 22-hydroxycholesterol results in increased expression of NR1H3 mRNA 22-hydroxycholesterol results in increased activity of NR1H3 protein
22-hydroxycholesterol promotes the reaction [Lipopolysaccharides results in increased expression of SELE mRNA] 22-hydroxycholesterol results in increased expression of SELE mRNA
[22-hydroxycholesterol co-treated with Alitretinoin] inhibits the reaction [Arsenic Trioxide results in decreased expression of SREBF1 protein] 22-hydroxycholesterol promotes the reaction [SREBF1 protein binds to ALDH1A1 promoter]; 22-hydroxycholesterol promotes the reaction [SREBF1 protein binds to ALDH1A2 promoter] 22-hydroxycholesterol results in increased expression of SREBF1 mRNA; 22-hydroxycholesterol results in increased expression of SREBF1 protein
22-hydroxycholesterol inhibits the reaction [IFNG results in increased phosphorylation of and results in increased localization of STAT1 protein]; [22-hydroxycholesterol co-treated with Alitretinoin] inhibits the reaction [IFNG promotes the reaction [STAT1 protein binds to CCL2 promoter]]; [22-hydroxycholesterol co-treated with Alitretinoin] inhibits the reaction [IFNG results in increased expression of STAT1 mRNA]
22-hydroxycholesterol promotes the reaction [Lipopolysaccharides results in increased expression of VCAM1 mRNA] 22-hydroxycholesterol results in increased expression of VCAM1 mRNA